Co-oxydextran as a protectant against gentamicin-induced renal lysosomal phospholipidosis and focal tubular necrosis. Perspectives and limitations.
Kishore
B K
BK
Laboratoire de Chimie Physiologique, Université Catholique de Louvain, Belgium.
Van Schepdael
A
A
Laurent
G
G
Lambricht
P
P
Claes
P J
PJ
Piret
J
J
Tulkens
P M
PM
Maldague
P
P
D000818:Animals; D000838:Anions / Q000627:therapeutic use*; D002455:Cell Division / Q000187:drug effects; D003911:Dextrans / Q000627:therapeutic use*; D005260:Female; D005839:Gentamicins / Q000037:antagonists & inhibitors*; D007674:Kidney Diseases / Q000517:prevention & control*; D007683:Kidney Tubular Necrosis, Acute / Q000473:pathology / Q000517:prevention & control*; D008247:Lysosomes / Q000187:drug effects* / Q000378:metabolism; D010741:Phospholipases A / Q000037:antagonists & inhibitors; D010743:Phospholipids / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley
D000838:Anions; D003911:Dextrans; D005839:Gentamicins; D010743:Phospholipids; D010741:Phospholipases A